The Motley Fool

Insiders have been buying these 3 ASX shares

Once a week I like to look at which ASX shares have been experiencing insider buying. This is because insider buying is often regarded as a bullish indicator as few should know a company, its prospects, and true value better than its own directors.

Three shares which have been experiencing meaningful insider buying recently are listed below:

Hydroponics Company Ltd (ASX: THC)

Two change of director’s interest notices reveal that this medicinal cannabis company has experienced a bout of insider buying this week. Board members Lou Cattelan and Gary Radcliff have picked up their second parcel of shares in the company since being voted in earlier this year. Mr Cattelan picked up 88,495 shares for a total consideration of $51,323.61 through on-market trades. This works out to be approximately 58 cents per share. Mr Radcliff bought 38,616 shares though on-market trades for a total consideration of $23,369.60 or 60.5 cents per share. Hydroponics Company’s shares are currently trading at 59 cents.

Liquefied Natural Gas Ltd (ASX: LNG)

According to a change of director’s interest notice released this morning, this liquefied natural gas company’s chairman, Paul Cavicchi, has been buying its US-listed over the counter ADRs. Mr Cavicchi bought 100,000 ADRs, which equates to 400,000 ordinary shares, this week for a total consideration of US$168,750. Despite its shares and ADRs rising by around 50% over the last 10 weeks, Mr Cavicchi clearly still sees a lot of value in them. As does CEO Gregory Vesey who picked up 150,000 ordinary shares at 56 cents per share yesterday. The company’s share price has rallied higher on the news.

Sigma Healthcare Ltd (ASX: SIG)

A change of director’s interest notice reveals that the chairman of this embattled pharmacy chain operator and distributor has been buying shares on-market. Brian Jamieson has taken advantage of Sigma’s significant share price decline to top up his holding by 50,000 shares for a total consideration of $24,000. This lifts Mr Jamieson’s holding to 830,078 shares. While I wouldn’t be a buyer of its shares just yet, not everyone is as bearish as I am. A note out of Citi this week declared Sigma as a (high risk) buy with a price target of 55 cents. Its shares are currently priced at 46.7 cents.

Instead of Sigma I would be buying this ASX small cap which is up 285% with no sign of stopping...

One Australian company has developed a state of the art device that's revolutionizing hospitals all over the world. Even better, this device is so profitable that the company rakes in 90% margins. That's a lot of cash. So no wonder the stock's up 285% since 2008 – with no signs of stopping...

To discover the name and code, simply click the link below. You'll discover our expert's #1 medical technology pick... and you can decide for yourself whether to get invested today.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

NEW. Five Cheap and Good Stocks to Buy in 2019…

Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.

One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield…

Plus 3 more cheap bets that could position you to profit over the next 12 months!

See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.